I’m pretty sure that it’s incorrect to say that the Australian results did not achieve statistical significance.
Also, why would non-inflammatory lesions not be important if they were lesions that had not YET become inflamed or broken through the skin? Would it not be better for the treatment longer term to be able to nip these in the bud?
- Forums
- ASX - By Stock
- BOT
- Objective Views on Lead product: BTX 1503 (Acne)
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
9.68%
!
34.0¢

Objective Views on Lead product: BTX 1503 (Acne), page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
34.0¢ |
Change
0.030(9.68%) |
Mkt cap ! $666.7M |
Open | High | Low | Value | Volume |
31.0¢ | 35.0¢ | 31.0¢ | $3.702M | 11.12M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 278570 | 33.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 257100 | 0.335 |
8 | 371349 | 0.330 |
6 | 263690 | 0.325 |
6 | 290115 | 0.320 |
7 | 489887 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 115000 | 3 |
0.350 | 149326 | 6 |
0.355 | 153000 | 3 |
0.360 | 83860 | 6 |
0.370 | 260842 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online